ACLU attorneys fear the use of facial recognition technology could be invasive to Americans and migrants alike.
Arrowhead Pharmaceuticals has received approval from the Australian TGA for Redemplo to treat familial chylomicronemia syndrome.
Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's disease.
Senate Republicans say the dysfunction in the House is becoming a liability for the broader GOP brand ahead of this year’s midterm elections, warning that if …
حذرت منظمة الصحة العالمية، من الملح الخفي في الأطعمة اليومية، مؤكدة، إنه يرفع ضغط الدم ويعرض الملايين للخطر، مضيفة، إنه من ما لا تراه قد يضر …